|
Greenspace Herbs is leading the way in the next generation of botanical wellness with its Quantum Ayurveda platform. It is addressing these pharmacokinetic limitations with Berberine QA. The formulation uses its own "Quantum Ayurveda" technology to improve the energetic profile of the substance so that cells can take it in better.
As metabolic health remains a dominant driver in the nutraceutical sector, berberine has emerged as a high-growth botanical, frequently categorized in consumer media as a natural GLP-1 alternative. But the industry has had a problem for a long time: low oral bioavailability. To reach therapeutic levels, traditional berberine supplementation usually needs high-frequency dosing of 1,500mg/day, which can cause adverse effects in the GI tract and make it hard for patients to stick to their treatment plan, said the company note.
Berberine QA provides metabolic assistance at a much lower dose of 500mg per day by making molecules work better. This 66% cut in the amount of berberine needed solves the main problems in the berberine market which is better gastric tolerance and adherence, said the company.
Shafiulla Hirehal Nuruddin, founder and managing director, Greenspace Herbs, said, "We are focused on optimising the delivery mechanism of established botanicals." "Our Quantum Ayurveda technology allows the body to utilize the compound more effectively, ensuring that the therapeutic benefits are achieved without the burden of high-dose regimens."
The shift toward metabolic wellness—encompassing glycaemic control, lipid management, and weight homeostasis—shows no signs of slowing. With the global berberine market projected to more than double over the next decade, the industry is moving away from "dosage wars" and toward sophisticated delivery science. Berberine QA positions itself at the intersection of this trend, offering a clinical-grade solution that balances efficacy with the practicalities of patient usage, he added.
|